CD79A and melanoma: CD138+ IgA+ plasma cells have been described in human primary melanomas particularly of >2 mm in thickness, where plasma cell-rich tumors—as identified by staining for CD138—had a worse overall survival than plasma-sparse ones (Bosisio et al., 2016).